TumorGen is developing a novel drug discovery platform to identify unseen therapeutic targets associated with cancer metastasis. Their patented technology is used to capture circulating metastatic cancer cell clusters (MCCCs).

Biotechnology

TumorGen

TumorGen's headquarters in San Diego, CA, United States

Jeffrey K. Allen

David H. Crean

Steve Robinson

Peter Teriete

Ezra Cohen

Gregory Botta

Peter Coassin

Darren Finlay

Sandip Patel

Samuel K. Kassegne

The Advisory Team at TumorGen comprises a group of experienced industry experts who provide strategic guidance and insights to enhance the company's drug discovery initiatives. They leverage their extensive knowledge in oncology and drug development to refine research directions, foster partnerships, and ensure alignment with regulatory standards, ultimately supporting TumorGen's mission to advance therapeutic targets for cancer metastasis.

Advisory Team

The Leadership Team at TumorGen guides the strategic direction and vision of the company, driving innovation in cancer research and drug discovery. Comprising key founders and scientific leaders, the team leverages their expertise to advance the development of the patented technology that captures circulating metastatic cancer cell clusters, facilitating breakthroughs in therapeutic target identification and enhancing TumorGen's impact in oncology.

TumorGen

Org chart

Board & advisors

Teams

Advisory Team

Leadership Team

Offices

TumorGen

Org chart

Board & advisors

Teams

Advisory Team

Leadership Team

Offices

Related companies